This finding aligns with a recent study that utilised cycloheximide acid as an antioxidant to combat DSS-induced colitis in mice, where colitis was similarly ameliorated by regulating the Nrf2/Keap1 pathway and antioxidative enzymes [49]. The gene discussed is KEAP1; the disease is colitis.